Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vivitrol + MET/CBT for Cannabis Use Disorder
NCT04139668Phase 2Terminated
- Sponsor
- Center for Addiction and Mental Health
- Start
- Jun 2021
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone in cannabis use disorder (CUD), sponsored by Center for Addiction and Mental Health. Started Jun 2021; status: terminated.
02
Drugs
naltrexone
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT04139668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04139668.